Categories AlphaGraphs, Analysis, Earnings, Retail

Earnings preview: Blue Apron’s Q2 results might turn out bland

Blue Apron Holdings (NYSE: APRN) is scheduled to report its second quarter 2019 earnings results on Tuesday, August 6, before market open. Analysts expect the company to report a loss of $1.08 per share on revenue of $138 million.

There appears to be very little optimism surrounding Blue Apron in general. The company’s business model is both expensive and inefficient and it does not offer much incentive in terms of attracting new customers or retaining existing ones.

Blue Apron Holdings (NYSE: APRN) reported a narrower loss in the first quarter of 2019.

Blue Apron also faces tough competition from other delivery services as well as retailers like Walmart (NYSE: WMT) and Kroger (NYSE: KR) who offer lower-priced meal kits in their stores. This significantly hurts the company’s business.

In June, Blue Apron announced a 1-for-15 reverse stock split which helped it avoid delisting from the NYSE. Last month, the company announced it would start offering plant-based products from Beyond Meat (NASDAQ: BYND) on its menus from August.

Wall Street remains unimpressed with these two moves. Analysts do not see much benefit coming out of these actions and even though Blue Apron’s shares had spiked 20% on the Beyond Meat-alliance news, it was considered nothing more than a halo effect.

Analysts do not believe the partnership with Beyond Meat can save Blue Apron and the sentiment surrounding Blue Apron’s future prospects is bleak. Blue Apron would require a change in strategy fast in order to survive in this difficult environment.

In the first quarter of 2019, Blue Apron missed top line estimates while the bottom line was narrower-than-expected. Revenue fell 28% year-over-year to $141.9 million while net loss narrowed to $0.03 per share from $0.17 per share last year. Orders fell 29% while the number of customers dropped 30% from a year ago.

Blue Apron’s shares have dropped 52% year-to-date and 48% over the past three months. The stock has an average 12-month price target of $6.00.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top